Standard Biotools (LAB) Cash from Operations Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 127.29 Bn | 123.81 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.14 Bn | 72.60 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.68 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -12.60% |
| 10 | Standard Biotools | 251.49 Mn | -225.23 Mn | 10.54 Mn | 50.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.11% |
| Mar 31, 2026 | -53.87% |
| Dec 31, 2025 | 91.54% |
| Sep 30, 2025 | 20.33% |
| Jun 30, 2025 | 47.07% |
| Mar 31, 2025 | 51.53% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | -144.21% |
| Jun 30, 2024 | -318.59% |
| Mar 31, 2024 | -636.31% |
| Dec 31, 2023 | 26.69% |
| Sep 30, 2023 | 53.63% |
| Jun 30, 2023 | 68.89% |
| Mar 31, 2023 | 45.57% |
| Sep 30, 2022 | 33.59% |
| Jun 30, 2022 | -8.79% |
| Mar 31, 2022 | -20.84% |
| Sep 30, 2021 | -705.81% |
| Jun 30, 2021 | -887.99% |
| Mar 31, 2021 | -200.37% |